Boehringer Ingelheim International GmbH – Company Profile & SWOT Analysis

Boehringer Ingelheim International GmbH – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company’s products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Scope

Detailed information on Boehringer Ingelheim International GmbH required for business and competitor intelligence needs

A study of the major internal and external factors affecting Boehringer Ingelheim International GmbH in the form of a SWOT analysis

An in-depth view of the business model of Boehringer Ingelheim International GmbH including a breakdown and examination of key business segments

News about Boehringer Ingelheim International GmbH, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Boehringer Ingelheim International GmbH and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Boehringer Ingelheim International GmbH as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Boehringer Ingelheim International GmbHs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Phibro Animal Health Corp

Pfizer Inc

Novartis AG

Jurgen Schmidt Chemievertretung GmbH

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Bristol-Myers Squibb Co

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Boehringer Ingelheim International GmbH - Key Facts

Boehringer Ingelheim International GmbH - Key Employees

Boehringer Ingelheim International GmbH - Key Employee Biographies

Boehringer Ingelheim International GmbH - Major Products and Services

Boehringer Ingelheim International GmbH - History

Boehringer Ingelheim International GmbH - Company Statement

Boehringer Ingelheim International GmbH - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Boehringer Ingelheim International GmbH - Business Description

Business Segment: Animal Health

Overview

Performance

Business Segment: Biopharmaceuticals

Overview

Performance

Key Stats

Business Segment: Human Pharmaceuticals

Overview

Performance

Business Segment: Other Sales

Overview

Performance

Geographical Segment: Asia/Australia/Africa

Performance

Geographical Segment: Europe

Performance

Geographical Segment: The Americas

Performance

R&D Overview

Boehringer Ingelheim International GmbH - Corporate Strategy

Boehringer Ingelheim International GmbH - SWOT Analysis

SWOT Analysis - Overview

Boehringer Ingelheim International GmbH - Strengths

Boehringer Ingelheim International GmbH - Weaknesses

Boehringer Ingelheim International GmbH - Opportunities

Boehringer Ingelheim International GmbH - Threats

Boehringer Ingelheim International GmbH - Key Competitors

Section 3 Company’s Lifesciences Financial Deals and Alliances

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

Section 4 Company’s Recent Developments

Jun 03, 2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya

May 31, 2019: Boehringer collaborates with Gubra for obesity treatments

May 23, 2019: Network of 1,500 stroke-ready clinics across Europe

May 14, 2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners

Apr 18, 2019: Boehringer partners PureTech to develop immuno-oncology candidates

Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests

Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed

Feb 12, 2019: Boehringer Ingelheim (Canada) and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials

Jan 17, 2019: Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities

Jan 08, 2019: Adimab provides year-end update on 2018 partnership activities

Section 5 Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Boehringer Ingelheim International GmbH, Key Facts

Boehringer Ingelheim International GmbH, Key Employees

Boehringer Ingelheim International GmbH, Key Employee Biographies

Boehringer Ingelheim International GmbH, Major Products and Services

Boehringer Ingelheim International GmbH, History

Boehringer Ingelheim International GmbH, Other Locations

Boehringer Ingelheim International GmbH, Subsidiaries

Boehringer Ingelheim International GmbH, Key Competitors

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

List of Figures

List of Figures

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports